Form 8-K Humacyte, Inc. For: Nov 21
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/12/2026
- S&P 500, Dow rise on Mideast deal hopes, SpaceX's historic debut
- SpaceX prices historic IPO at $135/share in largest ever new listing
- 'Ocean of opportunity': Wolfe initiates SpaceX at Buy ahead of historic IPO
- UBS cuts gold price forecasts on delayed Fed easing outlook
- Oil nears two-month lows on reports of imminent US-Iran peace deal
- NASDAQ adds five companies to NASDAQ-100 index in quarterly rebalance
- Adobe CFO Dan Durn to depart company in June 2026
- Oppenheimer Starts SpaceX (SPCX) at Outperform, PT $190, 'space infrastructure appears structurally advantaged'
- Pentagon reportedly locked down, hazmat teams responding
- Wall St set to gain on tech rebound, Middle East in focus
Humacyte terminates stock sale agreement with Jefferies
November 26, 2025 5:06 PM ESTHumacyte Inc. (NASDAQ: HUMA) terminated its stock sale agreement with Jefferies LLC, the company announced. The termination notice was delivered on November 21, 2025, and will become effective 10 days later under the agreement terms.
The Open Market Sale Agreement, originally entered into on September 1,... More
